A Clinical trial to study the effect of the drug Guru Parpam in the management of the patients having Polyarthritis(Santhu vatham)

Phase II Non-Randomized Open Clinical Evaluation Of Siddha Medicine Guru Parpam For The Management Of Santhu Vatham (Polyarthritis)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/11/037714

Enrollment

Registered

2021-11-01

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M060- Rheumatoid arthritis without rheumatoid factor

Interventions

Intervention1: Guru Parpam: 488mg(1 Panavedai) of Guru Parpam is administered twice a day in ginger juice for 48 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Joint pain Swelling Stiffness Tenderness Restricted movements Post viral arthritis Seronegative RA

Exclusion criteria

Exclusion criteria: Pregnancy and lactating women Rheumatic fever Rheumatoid arthritis

Design outcomes

Primary

Measure	Time frame
Primary Outcome is mainly assessed by reduction in clinical symptoms measured by universal pain assessment scaleTimepoint: 48 days	—

Secondary

Measure	Time frame
Secondary Outcome is mainly assessed by comparing the safety parameters before and after treatmentTimepoint: 48 days	—

Countries

India

Contacts

Public ContactDr Pavithra k

Government Siddha Medical College

nanbu.sumi@gmail.com9443279412

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026